Yan X, Cheng Y, Zhang X, Hu Y, Huang H, Ren J
Mol Oncol. 2022; 16(19):3509-3532.
PMID: 35900231
PMC: 9533685.
DOI: 10.1002/1878-0261.13296.
Brzozowa-Zasada M
Prz Gastroenterol. 2022; 17(2):162-168.
PMID: 35664020
PMC: 9165326.
DOI: 10.5114/pg.2022.116389.
Chen Y, Xie Y, Liu Z, Chen W, Zhang R, Ye H
Mol Med. 2022; 28(1):9.
PMID: 35090386
PMC: 8796544.
DOI: 10.1186/s10020-021-00425-w.
Ye L, Cheng Z, Cheng X, Huang Y
Toxicol Res (Camb). 2021; 10(4):696-705.
PMID: 34745557
PMC: 8561266.
DOI: 10.1093/toxres/tfab047.
Xiu M, Wang Y, Li B, Wang X, Xiao F, Chen S
Front Mol Biosci. 2021; 8:694141.
PMID: 34195229
PMC: 8237348.
DOI: 10.3389/fmolb.2021.694141.
Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy.
Yang X, Zhong J, Zhang Q, Feng L, Zheng Z, Zhang J
Front Mol Biosci. 2021; 8:662579.
PMID: 33968990
PMC: 8100458.
DOI: 10.3389/fmolb.2021.662579.
Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms.
Lin Y, Chen T, Huang Y, Wei P, Lin J
Biomedicines. 2021; 9(4).
PMID: 33805515
PMC: 8065716.
DOI: 10.3390/biomedicines9040343.
Prognosis model of colorectal cancer patients based on , , and mutations.
Liu K, Wang J, Zhan Y, Kong D, Wang C
J Gastrointest Oncol. 2021; 12(1):79-88.
PMID: 33708426
PMC: 7944156.
DOI: 10.21037/jgo-21-28.
Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
Kyriazi A, Papiris E, Kitsos Kalyvianakis K, Sakellaris G, Baritaki S
Int J Mol Sci. 2020; 21(18).
PMID: 32932969
PMC: 7556003.
DOI: 10.3390/ijms21186658.
Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes.
Wu Y, Pu N, Su W, Yang X, Xing C
J Cancer. 2020; 11(16):4832-4840.
PMID: 32626530
PMC: 7330696.
DOI: 10.7150/jca.44753.
miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.
Pidikova P, Reis R, Herichova I
Int J Mol Sci. 2020; 21(13).
PMID: 32610706
PMC: 7369991.
DOI: 10.3390/ijms21134633.
The Role of in Cancer.
Aburjania Z, Jang S, Whitt J, Jaskula-Stzul R, Chen H, Rose J
Oncologist. 2018; 23(8):900-911.
PMID: 29622701
PMC: 6156186.
DOI: 10.1634/theoncologist.2017-0677.
Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.
Wang J, Huang J, Chen G, Wei D
Mol Med Rep. 2018; 17(4):5013-5020.
PMID: 29393467
PMC: 5865962.
DOI: 10.3892/mmr.2018.8532.
Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers.
Pan Y, Mao Y, Jin R, Jiang L
Oncol Lett. 2017; 15(1):31-40.
PMID: 29285185
PMC: 5738678.
DOI: 10.3892/ol.2017.7294.
Notch and its oncogenic activity in human malignancies.
Brzozowa-Zasada M, Piecuch A, Michalski M, Segiet O, Kurek J, Harabin-Slowinska M
Eur Surg. 2017; 49(5):199-209.
PMID: 29104587
PMC: 5653712.
DOI: 10.1007/s10353-017-0491-z.
NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?.
Huang T, Zhou Y, Cheng A, Yu J, To K, Kang W
Mol Cancer. 2016; 15(1):80.
PMID: 27938406
PMC: 5148895.
DOI: 10.1186/s12943-016-0566-7.
miRNA-30e regulates abnormal differentiation of small intestinal epithelial cells in diabetic mice by downregulating Dll4 expression.
Shan T, Ouyang H, Yu T, Li J, Huang C, Yang H
Cell Prolif. 2016; 49(1):102-14.
PMID: 26786283
PMC: 6496571.
DOI: 10.1111/cpr.12230.
Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis.
Lopez-Dee Z, Chittur S, Patel H, Chinikaylo A, Lippert B, Patel B
PLoS One. 2015; 10(10):e0139918.
PMID: 26461935
PMC: 4603676.
DOI: 10.1371/journal.pone.0139918.
Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.
Mitchelson K, Qin W
World J Biol Chem. 2015; 6(3):162-208.
PMID: 26322174
PMC: 4549760.
DOI: 10.4331/wjbc.v6.i3.162.
Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X, Xu X, Li S, Wu S, Chen R, Jiang Q
PLoS One. 2015; 10(3):e0120024.
PMID: 25803870
PMC: 4372559.
DOI: 10.1371/journal.pone.0120024.